Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1990
Neuronal subsets express multiple high-molecular-weight cell-surface glycoconjugates defined by monoclonal antibodies Cat-301 and VC1.1S Zaremba, J R Naegele, C J Barnstable, et al.International Journal of Cancer|March 10, 2000
Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptideE Salazar, S Zaremba, P M Arlen, et al.European Journal of Immunology|February 1, 1996
Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responsesS I Abrams, S F Stanziale, S D Lunin, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1998
Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptideP Correale, K Walmsley, S Zaremba, et al.Cancer Research|October 23, 1997
Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigenS Zaremba, E Barzaga, M Zhu, et al.British Journal of Anaesthesia|June 19, 2008
Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathingM Eikermann, S Zaremba, A Malhotra, et al.Journal of the National Cancer Institute|February 19, 1997
In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigenP Correale, K Walmsley, C Nieroda, et al.Journal of the National Cancer Institute|July 5, 1995
Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccineK Y Tsang, S Zaremba, C A Nieroda, et al.International Journal of Cancer|January 2, 1993
Biologic properties of a CH2 domain-deleted recombinant immunoglobulinD C Slavin-Chiorini, P H Horan Hand, S V Kashmiri, et al.Seminars in Oncology|December 22, 1999
Strategies in the development of recombinant vaccines for colon cancerJ Schlom, K Y Tsang, J A Kantor, et al.Pageof 3